Filter
881
Filtered Results: 881
Text search:
World
Health
Organization
WHO,
PAHO
Featured
Recommendations
96
New Publications
166
Language
Document type
No document type
335
Studies & Reports
181
Guidelines
151
Manuals
71
Fact sheets
36
Strategic & Response Plan
35
Training Material
31
Situation Updates
20
Infographics
8
Resource Platforms
5
Online Courses
4
Brochures
3
App
1
Countries / Regions
Latin America and the Carribbean
133
Global
49
Brazil
32
Haiti
27
Colombia
21
Venezuela
21
Mozambique
11
Nepal
10
Angola
10
North America
9
Africa
7
Guinea-Bissau
7
Paraguay
7
Russia
6
India
6
Syria
5
Peru
5
Ukraine
4
Chile
4
Asia
4
Middle East and North Africa
4
Bangladesh
4
Yemen
4
South Sudan
4
El Salvador
3
Ghana
3
Nigeria
3
Philippines
3
Argentina
3
Myanmar / Burma
3
Thailand
2
China
2
Cambodia
2
South–East Asia Region
2
Jamaica
2
Portugal
2
Belarus
2
East and Southern Africa
2
South Africa
2
Ethiopia
2
Zambia
2
Ecuador
2
North Macedonia
1
Tajikistan
1
Mexico
1
Lesotho
1
Turkey
1
Benin
1
Sierra Leone
1
Rwanda
1
Kazakhstan
1
Cameroon
1
Iran
1
Laos
1
Estonia
1
Zimbabwe
1
Italy
1
Armenia
1
USA
1
Dominican Republic
1
Tanzania
1
West and Central Africa
1
Western Pacific Region
1
Western and Central Europe
1
Uruguay
1
Japan
1
Belgium
1
Bolivia
1
Vietnam
1
Uganda
1
Eastern Europe
1
Moldova
1
Sudan
1
Georgia
1
Honduras
1
Liberia
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
212
Clinical Guidelines
98
Key Resources
77
Public Health
59
Women & Child Health
48
Capacity Building
14
Pharmacy & Technologies
8
Annual Report MEDBOX
1
Toolboxes
COVID-19
173
Mental Health
92
Rapid Response
57
HIV
51
Zika
45
NTDs
42
Planetary Health
38
Natural Hazards
32
TB
26
Caregiver
24
NCDs
24
Global Health Education
24
AMR
20
Cholera
15
Pharmacy
14
Health Financing Toolbox
12
Disability
11
Conflict
11
Refugee
8
Specific Hazards
7
Typhoon
4
Ebola
3
Polio
2
23 February 2021
This document describes the medical devices required for the clinical management of COVID-19, selected and prioritized according to the latest available evidence and interim guidelines. This includes: oxygen therapy, pulse oximeters, patient monitors, thermometers, infusion and suc...
Biweekly situation reports
The recommendations cover the level of blood pressure to start medication, what type of medicine or combination of medicines to use, the target blood pressure level, and how often to have follow-up checks on blood pressure. In addition, the guideline provides the basis for how physicians and other h...
The portable diagnostic imaging technology covered by this document will serve not only the pressing demands for tuberculosis screening and triage but also other diseases. Therefore, the requirements, accessories, hardware and software packages listed in the following specifications are described in...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons...
Poster
Stop filariasis now
do the right thing to save the next generation
This document outlines the working structure and guiding principles for collaboration of COVAX, the Vaccines pillar of the Access to COVID-19 Tools Accelerator (ACT-A). The working structure of COVAX continues to adapt to emerging needs and the changing trajectory of the pandemic. Some components of...
Background: The World Health Organization (WHO) published a clinical case definition of post COVID-19
condition, by a Delphi consensus, on 6 October 2021. That process concluded that a separate definition
may be applicable for children. It is important to understand the frequency, characteristics ...
Pathogen genomic surveillance has become a priority for public health systems in recent years. Genomic sequencing is increasingly being used to characterize pathogens and monitor important public health priorities (e.g. poliovirus, influenza virus, Mycobacterium tuberculosis and Vibrio cholerae, ant...
This publication aims to provide updated guidance on the specific use of yellow fever laboratory assays in the context of surveillance to be used across the Global Yellow Fever Laboratory Network for disease surveillance. In the recent years, new commercial assays became available and are now recomm...
Since the launch of the 2012–2020 World Health Organization (WHO) road map for the control, elim-ination and eradication of neglected tropical diseases (NTDs) (1), considerable progress against NTDs has been made. Between 2010 and 2020, the number of people requiring interventions against NTDs glo...
Evidence-based psychological interventions are an important part of health, social, protection and education services and can help increase access to effective mental health treatments and progression towards universal health coverage.
This manual provides managers and others responsible for plan...
This country profile presents a summary and analysis of Argentina's status with yellow fever. It is part of a series of profiles on this topic, each focusing on a different country in the Region of the Americas. Argentina's geographical location presents a wide territorial extension throughout diffe...
Временные рекомендации
9 августа 2021 г.
Цель данного документа - описать минимальный набор мероприятий по эпиднадзору, рекомендуемых на национальном уровне для вы...
Emergency Preparedness for the Health Sector: Challenges and Way Forward. Expert Consultation.
Preparedness is nowadays defined as an integrated set of long term multi-sectoral activities. One key objective is to contribute to the achievement of an increasing level of readiness within the MOH and t...
The report focuses on antibacterial resistance (ABR) in common bacterial pathogens. There is a major gap in knowledge about the magnitude of this problem. Antimicrobial resistance (AMR) threatens the effective revention and treatment of an ever-increasing range of infections caused by bacteria, para...
The strategy focuses on mobilizing and coordinating partners, experts and resources to help countries enhance surveillance of the Zika virus and disorders that could be linked to it, improve vector control, effectively communicate risks, guidance and protection measures, provide medical care to thos...
Bulletin of the World Health Organization 2016. doi: http://dx.doi.org/10.2471/BLT.16.171082
Objective: To describe the temporal and geographical distribution of Zika virus infection, and associated neurological disorders, from 1947 to February 2016.
